News Releases Items Per Page 102550 Year None20212020201920182017201620152012 Jun 28, 2021 Galera Announces Completion of Enrollment in Pivotal 455-Patient Phase 3 Trial of Avasopasem for Severe Oral Mucositis View HTML PDF Version May 26, 2021 Galera to Present at the Jefferies Virtual Healthcare Conference View HTML PDF Version May 17, 2021 Galera Announces First Patient Dosed with GC4711 in Phase 2b GRECO-2 Trial in Patients with Pancreatic Cancer View HTML PDF Version May 12, 2021 Science Translational Medicine Article Shows Galera’s Selective Dismutase Mimetic Synergizes with Radiotherapy to Ablate Tumors View HTML PDF Version May 11, 2021 Galera Reports First Quarter 2021 Financial Results and Recent Accomplishments View HTML PDF Version May 05, 2021 Galera to Participate in the BofA Securities 2021 Virtual Healthcare Conference View HTML PDF Version Apr 28, 2021 Galera Announces Updated Data from its Randomized, Multicenter, Placebo-Controlled Trial in Patients with Pancreatic Cancer View HTML PDF Version Mar 11, 2021 Galera Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Accomplishments View HTML PDF Version Mar 10, 2021 Galera Therapeutics to Present at the Oppenheimer 31st Annual Healthcare Conference View HTML PDF Version results
